Modulation of the gut-liver axis by oxymatrine alleviates metabolic dysfunction-associated steatotic liver disease

Figure 2 Oxymatrine alleviates hepatic pathological damage and lipid accumulation in metabolic dysfunction-associated steatotic liver disease rats. A: Liver histology (hematoxylin eosin staining, representative images), 100 × (200 μm); 400 × (50 μm); B: Liver histology (oil red O staining, representative images). n = 6, 100 × (200 μm); 400 × (50 μm). ^aP < 0.05, ^bP < 0.01. Statistical analysis was conducted using one-way analysis of variance with Tukey’s post hoc test, and results are presented as mean ± SD. HE: Hematoxylin eosin; MET: Metformin; OMT: Oxymatrine; ORO: Oil red O.